C
Catherine A.W. Sullivan
Researcher at Yale University
Publications - 15
Citations - 2863
Catherine A.W. Sullivan is an academic researcher from Yale University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 10, co-authored 14 publications receiving 2370 citations. Previous affiliations of Catherine A.W. Sullivan include Yale Cancer Center.
Papers
More filters
Journal ArticleDOI
The contribution of de novo coding mutations to autism spectrum disorder
Ivan Iossifov,Brian J. O'Roak,Stephen Sanders,Stephen Sanders,Michael Ronemus,Niklas Krumm,Dan Levy,Holly A.F. Stessman,Kali Witherspoon,Laura Vives,Karynne E. Patterson,Joshua D. Smith,Bryan W. Paeper,Deborah A. Nickerson,Jeanselle Dea,Shan Dong,Shan Dong,Luis E. Gonzalez,Jeffrey D. Mandell,Shrikant Mane,Michael T. Murtha,Catherine A.W. Sullivan,Michael F. Walker,Zainulabedin Waqar,Liping Wei,A. Jeremy Willsey,A. Jeremy Willsey,Boris Yamrom,Yoon-ha Lee,Ewa A. Grabowska,Ertugrul Dalkic,Ertugrul Dalkic,Zihua Wang,Steven Marks,Peter Andrews,Anthony Leotta,Jude Kendall,Inessa Hakker,Julie Rosenbaum,Beicong Ma,Linda Rodgers,Jennifer Troge,Giuseppe Narzisi,Seungtai Yoon,Michael C. Schatz,Kenny Ye,W. Richard McCombie,Jay Shendure,Evan E. Eichler,Evan E. Eichler,Matthew W. State,Matthew W. State,Michael Wigler +52 more
TL;DR: It is estimated that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation.
Journal ArticleDOI
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Sriparna Ghosh,Catherine A.W. Sullivan,Maciej P. Zerkowski,Annette M. Molinaro,David L. Rimm,Robert L. Camp,Gina G. Chung +6 more
TL;DR: Tissue microarray analysis showed that high levels of vascular endothelial growth factor, VEGFR-1, V EGFR-2, and neuropilin-1 were all significantly associated with survival and retained a significant association with survival independent of other standard prognostic factors.
Journal ArticleDOI
De Novo Insertions and Deletions of Predominantly Paternal Origin Are Associated with Autism Spectrum Disorder
Shan Dong,Shan Dong,Michael F. Walker,Nicholas Carriero,Michael DiCola,A. Jeremy Willsey,A. Jeremy Willsey,Adam Yongxin Ye,Zainulabedin Waqar,Luis E. Gonzalez,John D. Overton,Stephanie Frahm,John F. Keaney,Nicole A. Teran,Jeanselle Dea,Jeffrey D. Mandell,Vanessa H. Bal,Catherine A.W. Sullivan,Nicholas M. DiLullo,Rehab O. Khalil,Jake Gockley,Zafer Yüksel,Sinem M. Sertel,A. Gulhan Ercan-Sencicek,Abha R. Gupta,Shrikant Mane,Michael Sheldon,Andrew Brooks,Kathryn Roeder,Bernie Devlin,Matthew W. State,Liping Wei,Stephen Sanders,Stephen Sanders +33 more
TL;DR: On the basis of mutation rates in probands versus unaffected siblings, it is concluded that de novo frameshift indels contribute to risk in approximately 3% of individuals with ASD.
Journal ArticleDOI
PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer
Joshua VanHouten,Catherine A.W. Sullivan,Caroline Bazinet,Tom Ryoo,Robert L. Camp,David L. Rimm,Gina G. Chung,John J. Wysolmerski +7 more
TL;DR: It is concluded that loss of PMCA2 expression at weaning triggers apoptosis by causing cellular calcium crisis, andPMCA2 overexpression, on the other hand, may play a role in breast cancer progression by conferring resistance to apoptosis.
Journal ArticleDOI
Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
Robert Lindner,Robert Lindner,Catherine A.W. Sullivan,Onyinye Offor,Kimberly Lezon-Geyda,Kyle Halligan,Neal Fischbach,Mansi Shah,Veerle Bossuyt,Vincent P. Schulz,David Tuck,Lyndsay Harris,Lyndsay Harris +12 more
TL;DR: Differences in TNBC subtypes and levels of tumor angiogenesis in AA versus EA patients suggest that targeted therapy choices should be considered in the context of race.